Zuoqing Li

506 total citations
23 papers, 348 citations indexed

About

Zuoqing Li is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Zuoqing Li has authored 23 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Immunology and 5 papers in Cancer Research. Recurrent topics in Zuoqing Li's work include Neuroblastoma Research and Treatments (4 papers), Signaling Pathways in Disease (3 papers) and Urological Disorders and Treatments (3 papers). Zuoqing Li is often cited by papers focused on Neuroblastoma Research and Treatments (4 papers), Signaling Pathways in Disease (3 papers) and Urological Disorders and Treatments (3 papers). Zuoqing Li collaborates with scholars based in China, United States and United Kingdom. Zuoqing Li's co-authors include Qigen Xie, Li Zhou, Juntao Xie, Minzhi Yin, Xiangcheng Zhou, Linheng Li, Jun Shi, Cai‐Wen Duan, Tao Ying and Xia Qin and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Cell and Biochemical and Biophysical Research Communications.

In The Last Decade

Zuoqing Li

21 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zuoqing Li China 10 179 92 86 74 50 23 348
Zhijie Bai China 8 251 1.4× 49 0.5× 58 0.7× 170 2.3× 31 0.6× 32 479
Anikó Újfalusi Hungary 10 205 1.1× 46 0.5× 38 0.4× 35 0.5× 25 0.5× 48 395
X Chen China 7 141 0.8× 46 0.5× 42 0.5× 61 0.8× 47 0.9× 12 361
Fanxing Zeng China 12 123 0.7× 51 0.6× 60 0.7× 75 1.0× 19 0.4× 29 428
Guo Liang Xu China 9 329 1.8× 38 0.4× 32 0.4× 42 0.6× 38 0.8× 18 459
Guy Ledergor United States 6 141 0.8× 140 1.5× 36 0.4× 67 0.9× 68 1.4× 10 303
Kazuomi Nakamura Japan 12 241 1.3× 20 0.2× 27 0.3× 99 1.3× 62 1.2× 28 475
Charlotta Böiers Sweden 12 157 0.9× 148 1.6× 15 0.2× 134 1.8× 54 1.1× 24 425
Gloria E. Hernandez United States 8 192 1.1× 74 0.8× 40 0.5× 181 2.4× 31 0.6× 11 396

Countries citing papers authored by Zuoqing Li

Since Specialization
Citations

This map shows the geographic impact of Zuoqing Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zuoqing Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zuoqing Li more than expected).

Fields of papers citing papers by Zuoqing Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zuoqing Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zuoqing Li. The network helps show where Zuoqing Li may publish in the future.

Co-authorship network of co-authors of Zuoqing Li

This figure shows the co-authorship network connecting the top 25 collaborators of Zuoqing Li. A scholar is included among the top collaborators of Zuoqing Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zuoqing Li. Zuoqing Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wen, Ke, et al.. (2025). Nutrient deficiency-induced downregulation of SNX1 inhibits ferroptosis through PPARs-ACSL1/4 axis in colorectal cancer. APOPTOSIS. 30(5-6). 1391–1409. 3 indexed citations
2.
3.
Yang, Xiaoyu, et al.. (2023). Impact of Repeated Infantile Exposure to Surgery and Anesthesia on Gut Microbiota and Anxiety Behaviors at Age 6–9. Journal of Personalized Medicine. 13(5). 823–823. 1 indexed citations
4.
Huang, Ying, Jieyi Ma, Hui Han, et al.. (2022). METTL1 promotes neuroblastoma development through m7G tRNA modification and selective oncogenic gene translation. Biomarker Research. 10(1). 68–68. 21 indexed citations
5.
Luo, Peng, et al.. (2022). 46,XY disorders of sex development: the use of NGS for prevalent variants. Human Genetics. 141(12). 1863–1873. 9 indexed citations
6.
Li, Zuoqing, et al.. (2022). Effect of Hypertonic Saline Solution Combined with Furosemide on Acute Heart Failure: A Meta-Analysis. Computational and Mathematical Methods in Medicine. 2022. 1–7.
7.
Xie, Qigen, Kai Xia, Xiangping Li, et al.. (2021). Application of the Mathieu combined tunnel technique for repairing glans dehiscence after failed hypospadias repair. Asian Journal of Andrology. 24(3). 311–316. 4 indexed citations
8.
Li, Zuoqing, et al.. (2019). GDNF family receptor alpha 2 promotes neuroblastoma cell proliferation by interacting with PTEN. Biochemical and Biophysical Research Communications. 510(3). 339–344. 18 indexed citations
9.
Li, Zuoqing, et al.. (2019). NLGN3 promotes neuroblastoma cell proliferation and growth through activating PI3K/AKT pathway. European Journal of Pharmacology. 857. 172423–172423. 17 indexed citations
10.
Xie, Juntao, et al.. (2018). Preliminary report of robotic surgery for congenital dilatation of bile duct. Zhonghua xiaoerwaike zazhi. 39(3). 200–203.
11.
Li, Zuoqing, et al.. (2016). miR-1303 promotes the proliferation of neuroblastoma cell SH-SY5Y by targeting GSK3β and SFRP1. Biomedicine & Pharmacotherapy. 83. 508–513. 35 indexed citations
12.
13.
Li, Zuoqing, et al.. (2014). A Trichosanthin-derived peptide suppresses type 1 immune responses by TLR2-dependent activation of CD8+CD28− Tregs. Clinical Immunology. 153(2). 277–287. 14 indexed citations
14.
Duan, Cai‐Wen, Jun Shi, Jing Chen, et al.. (2014). Leukemia Propagating Cells Rebuild an Evolving Niche in Response to Therapy. Cancer Cell. 25(6). 778–793. 140 indexed citations
15.
Xu, Zhe, Zuoqing Li, Benfu He, et al.. (2013). Sam68 is a novel marker for aggressive neuroblastoma. OncoTargets and Therapy. 6. 1751–1751. 9 indexed citations
16.
17.
Xu, Zhe, Hongyu Guan, Zuoqing Li, et al.. (2010). Clinical significance of the expression of sphingolipids kinase-1 in neuroblastoma. Zhonghua shiyan waike zazhi. 27(10). 1413–1414. 1 indexed citations
18.
Li, Zuoqing, et al.. (2009). Ureteral Triplication Combined with Right Renal Ectopia and Ureteral Cyst. Urologia Internationalis. 83(4). 476–478. 1 indexed citations
19.
Nie, Hui, Zuoqing Li, Ronald J. Lukas, et al.. (2007). Construction of SH-EP1-α4β2-hAPP695 Cell Line and Effects of Nicotinic Agonists on β-amyloid in the Cells. Cellular and Molecular Neurobiology. 28(1). 103–112. 10 indexed citations
20.
Li, Zuoqing, et al.. (1999). Clinical observation on radio- or chemo-therapy plus traditional Chinese medicine in treating brain metastases. Chinese Journal of Integrated Traditional and Western Medicine. 5(4). 246–246. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhijie Bai Breakdown of academic impact, for papers by Anikó Újfalusi Breakdown of academic impact, for papers by X Chen Breakdown of academic impact, for papers by Fanxing Zeng Breakdown of academic impact, for papers by Guo Liang Xu Breakdown of academic impact, for papers by Guy Ledergor Breakdown of academic impact, for papers by Kazuomi Nakamura Breakdown of academic impact, for papers by Charlotta Böiers Breakdown of academic impact, for papers by Gloria E. Hernandez
Rankless by CCL
2026